Pasireotide

پاسیرئوتید

⚠ Unverified

🧬 Systemic Hormonal Preparations, Excl. Sex Hormones And InsulinsSomatostatin analogue

Market / country: 🇺🇸 USA

Signifor (US)

🧮 Dose calculator

Cushing disease · Regimen source: FDA Signifor · 2.1

  • • Range 0.3–0.9 mg twice daily; titrate by urinary free cortisol. Before starting: FPG, HbA1c, liver tests, ECG, gallbladder ultrasound, potassium and magnesium. Child-Pugh B: start 0.3, max 0.6 mg twice daily; avoid in Child-Pugh C. FDA Signifor · 2.1FDA Signifor · 2.2FDA Signifor · 2.3

Enter age (weight is optional for this regimen).

🛡️ Safety & information

Warnings

  • • Hypocortisolism; hyperglycaemia and diabetes (common); bradycardia and QT prolongation; liver test elevations; cholelithiasis; deficiency of other pituitary hormones. FDA Signifor · 5

Formulations

👥 Special populations

  • 🤰 PregnancyUse with caution

    Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Signifor · 8.1

    “Risk Summary The limited data with SIGNIFOR in pregnant women are insufficient to inform a drug-associated risk for major birth defects and miscarriage.”
  • 🤱 BreastfeedingUse with caution

    Label: use with caution while breastfeeding; see the label text. FDA Signifor · 8.2

    “Risk Summary There is no information available on the presence of SIGNIFOR in human milk, the effects of the drug on the breastfed infant, or the effects of the drug on milk production.”
  • 👶 ChildrenUse with caution

    The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Signifor · 8.4

    “Safety and effectiveness of SIGNIFOR have not been established in pediatric patients.”
  • 👴 Older adultsUse with caution

    Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Signifor · 8.5

    “In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and concomitant disease or other drug therapy [see Clinical Pharmacology (12.3)] .”
  • ⚥ Females & males of reproductive potentialUse with caution

    Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Signifor · 8.3

    “… zation of serum cortisol levels in female patients with Cushing's disease treated with pasireotide may lead to improved fertility.”

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

🔗 Similar drugs

Same class

Doz is only a support tool and does not replace clinical judgment or official sources. Check every dose against the original source before prescribing. About & disclaimer · Sources

Information on this site is compiled from online websites and references. Doz accepts no responsibility for self-medication without approval from a physician and a reliable reference, or for any consequences of using this information.

Inspired by the Saphira project; part of the content is taken from it.

For suggestions, corrections, adding drugs or anything else, you can contact me on Telegram: @cenaav